Citations for
1AGER, S100B
S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.
Villarreal A, Aviles Reyes RX, Angelo MF, Reines AG, Ramos AJ.
J Neurochem 117(2):321-32. doi: 10.1111/j.1471-4159.2011.07207.x. Epub 2011 Feb 25. 2011
2AGER, S100B
S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner.
Riuzzi F, Sorci G, Donato R.
J Cell Sci 124(Pt 14):2389-400. Epub 2011 Jun 21. 2011
3AGER, ICAM1
RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo.
Frommhold D, Kamphues A, Hepper I, Pruenster M, Lukic IK, Socher I, Zablotskaya V, Buschmann K, Lange-Sperandio B, Schymeinsky J, Ryschich E, Poeschl J, Kupatt C, Nawroth PP, Moser M, Walzog B, Bierhaus A, Sperandio M.
Blood 116(5):841-9. Epub 2010 Apr 20.PMID: 20407037 2010
4AGER, HMGB1
The role of HMGB1/RAGE in inflammatory cardiomyopathy.
Volz HC, Kaya Z, Katus HA, Andrassy M.
Semin Thromb Hemost 36(2):185-94. Epub 2010 Apr 22. Review.PMID: 20414834 2010
5AGER, TXNIP
RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion.
Sbai O, Devi TS, Melone MA, Feron F, Khrestchatisky M, Singh LP, Perrone L.
J Cell Sci 123(Pt 24):4332-9. Epub 2010 Nov 23. 2010
6AGER, DDOST
Expression of advanced glycation end-product receptors in the cochlea.
Hanusek C, Setz C, Radojevic V, Brand Y, Levano S, Bodmer D.
Laryngoscope 120(6):1227-32. 2010
7AGER
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.
Sterenczak KA, Willenbrock S, Barann M, Klemke M, Soller JT, Eberle N, Nolte I, Bullerdiek J, Murua Escobar H.
Gene 434(1-2):35-42. Epub 2008 Nov 12. 2009
8AGER
RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.
Chuong C, Katz J, Pauley KM, Bulosan M, Cha S.
J Cell Physiol 221(2):430-4. 2009
9AGER
RAGE: a novel biological and genetic marker for vascular disease.
Kalea AZ, Schmidt AM, Hudson BI.
Clin Sci (Lond) 116(8):621-37. Review. 2009
10AGER
Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus.
Goulart AC, Germer S, Rexrode KM, Martin M, Zee RY.
Clin Chim Acta 398(1-2):95-8. Epub 2008 Sep 3. 2008
11AGER
Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia.
Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H.
J Hypertens 26(9):1824-8. 2008
12AGER
Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, Shekhtman A.
J Biol Chem 283(40):27255-69. Epub 2008 Jul 30. 2008
13AGER
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME.
FASEB J 22(10):3716-27. Epub 2008 Jul 4. 2008
14AGER, FCGR1A, MRC1
Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis.
Arce-Mendoza A, Rodriguez-de Ita J, Salinas-Carmona MC, Rosas-Taraco AG.
Arch Med Res 39(3):306-11. 2008
15AGER
Identification, classification, and expression of RAGE gene splice variants.
Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM.
FASEB J 22(5):1572-80. Epub 2007 Dec 18.PMID: 18089847 2008
16AGER, CCNB2, CDK5RAP3
Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma.
Stav D, Bar I, Sandbank J.
Int J Biol Markers 22(2):108-13. 2007
17AGER
C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.
Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PW, Verma S.
Hypertension 48(3):504-11. Epub 2006 Jul 17. 2006
18AGER
Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor.
Cai W, He JC, Zhu L, Lu C, Vlassara H.
Proc Natl Acad Sci U S A 103(37):13801-6. Epub 2006 Sep 5. 2006
19AGER
The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients.
Lindholm E, Bakhtadze E, Sjögren M, Cilio CM, Agardh E, Groop L, Agardh CD.
Diabetologia 49(11):2745-55. Epub 2006 Sep 13. 2006
20AGER
RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.
Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B.
Nat Med 9(7):907-13. 2003
21APP, AGER
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
Yan SD, et al.
Nature 382 : 685-691. 1996
22NOTCH4, PBX2, AGER
Three genes in the human MHC class III region near the junction with the class II : gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3.
Sugaya K, et al.
Genomics 23 : 408-419. 1994
23AGER
Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3.
Vissing H, et al.
Genomics 24 : 606-608. 1994